Dr. Jen wrote on:17 alpha hydroxyprogesterone 17OP aluminum cerebral palsy congenital heart defect congenital heart disease disability eating disorder fine motor skill fine motor skills flu going home hands health insurance hypotonia influenza KV Pharmaceuticals losing a baby Makena March of Dimes medicaid NEC NICU omega-3 OT perseverance pertussis Play-Doh preeclampsia preemie progesterone RediWhip RSV running safety stress Synagis Tae Kwon Do tests Thanksgiving turkey vaccine vaccines whooping cough writing
- Preventing prematurity: the importance of getting screened for Chlamydia
- Ther-Rx skips ACOG: the people have spoken. But can we do more?
- What does replacing the word retarded with intellectual disability accomplish?
- Cigna’s automatic denials: asshattery in action
- ACOG’s double standard on Makena: denouncing Ther-Rx but taking advertising dollars
Author Archives: Jennifer Gunter
This whole Makena thing just keeps getting worse. Worse for women, because co-payments have sky rocketed and worse for the March of Dimes, whose every move proves they are just digging themselves a deeper hole. I read yesterday (March 22) … Continue reading
The senior vice president (SVP) of marketing for the March of Dimes (MOD) reached out to me via e-mail on Monday about Makena pricing. He wanted to let me know the March of Dimes is “doing all we can to ensure access for … Continue reading
March 21rst. Today is the day that Makena, KV pharmaceuticals “brand” of 17 alpha-hydroxyprogesterone caproate (17OP) hits the market. It’s not really a brand name drug. It has been used for a variety of indications in pregnancy since the 1950′s … Continue reading
The kids are learning money in school. Well, Victor is. For Oliver, money represents a major roadblock. His teacher told me that math is not his strong suit. He loves to buy things, so I thought money would come naturally. … Continue reading
The recent uproar over KV Pharmaceutical’s pricing of Makena, 17 alpha-hydoxyprogesterone caproate or 17OP for preterm labor, has left many wondering if Makena (and it’s $1,500 per shot/$30k per pregnancy price tage) can simply be avoided and pregnant women continue to get 17OP from compounding pharmacies (at the … Continue reading
Makena, KV Pharmaceuticals version of 17 alpha-hydroxyprogesterone caproate or 17OP (for prevention of preterm labor) is priced at $1500 a shot (up from $10 a shot prior to the meddling of the FDA). Considering most women who are eligible will … Continue reading
Both The March of Dimes and The American Congress of OB/GYN (and apparently a few other medical professional societies) supported KV Pharmaceuticals application to the FDA to be the sole manufacturer of 17 Alpha Hydroxyprogesterone caproate (17P), the hormone that … Continue reading
Preemie message boards are all fired up by KV Pharmaceutical’s pricing of 17 Alpha-hydroxy progesterone caproate (17P, a hormone than can help prevent premature delivery for some women who have previously delivered prematurely). Once KV was awarded the patent, the … Continue reading
Yesterday, March 9th, the price of gold was $1,429.74 an ounce. That same day KV Pharmaceuticals announced the drug 17 Alpha-Hydroxy Progesterone Caproate (17P), a hormone that can prevent preterm delivery, will now cost $1500 a shot. One injection of … Continue reading